Nakamura Katsumasa, Shioyama Yoshiyuki, Kawashima Mitsuhiko, Saito Yoshihiro, Nakamura Naoki, Nakata Kensei, Hareyama Masato, Takada Takahiro, Karasawa Kumiko, Watanabe Toshiichi, Yorozu Atsunori, Tachibana Hiroyuki, Suzuki Gen, Hayabuchi Naofumi, Toba Takashi, Yamada Shogo
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, and Division of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1045-50. doi: 10.1016/j.ijrobp.2006.02.001. Epub 2006 May 6.
To analyze the outcomes of patients with early hypopharyngeal cancer treated with radical radiotherapy (RT).
Ten institutions combined the data from 115 patients with Stage I-II hypopharyngeal squamous cell carcinoma treated with definitive RT between 1990 and 2001. The median patient age was 67 years; 99 patients were men and 16 were women. Of the 115 patients, 39 had Stage I and 76 had Stage II disease. Conventional fractionation was used in 98 patients and twice-daily RT in 17 patients; chemotherapy was combined with RT in 57 patients. The median follow-up period was 47 months.
The overall and disease-specific 5-year survival rate for 95 patients without synchronous malignancies was 66.0% and 77.4%, respectively. The 5-year disease-specific survival rate by T stage was 95.8% for patients with T1 disease and 70.1% for patients with T2 disease (p=0.02). Of the 115 patients, local control with laryngeal voice preservation was achieved in 34 of 39 patients with T1 lesions, including 7 patients successfully salvaged, and in 56 of 76 patients with T2 lesions. Sixty-five patients (56.5%) had synchronous or metachronous cancers. Of the 115 patients, 19 died of hypopharyngeal cancer, 10 died of second primary cancers, and 14 died of other causes during the study and follow-up periods.
Patients with early hypopharyngeal cancer tended to have a good prognosis after RT. However, second malignancies had an adverse effect on the overall outcomes of patients with early hypopharyngeal cancer.
分析接受根治性放疗(RT)的早期下咽癌患者的治疗结果。
10家机构汇总了1990年至2001年间115例接受根治性RT治疗的I-II期下咽鳞状细胞癌患者的数据。患者中位年龄为67岁;99例为男性,16例为女性。115例患者中,39例为I期,76例为II期。98例患者采用常规分割放疗,17例患者采用每日两次放疗;57例患者放疗联合化疗。中位随访期为47个月。
95例无同步恶性肿瘤患者的5年总生存率和疾病特异性生存率分别为66.0%和77.4%。T1期患者的5年疾病特异性生存率为95.8%,T2期患者为70.1%(p=0.02)。115例患者中,39例T1病变患者中有34例实现了保留喉功能的局部控制,其中7例成功挽救,76例T2病变患者中有56例实现了局部控制。65例患者(56.5%)有同步或异时性癌症。在研究和随访期间,115例患者中,19例死于下咽癌,10例死于第二原发癌,14例死于其他原因。
早期下咽癌患者放疗后预后往往较好。然而,第二原发恶性肿瘤对早期下咽癌患者的总体治疗结果有不利影响。